Offer - Urjas Oil for just ₹ 1 X
Duvadilan Tablet (50), a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Premature Labor. The alternative uses of Duvadilan Tablet (50) have also been explained below.
The optimal dosage of Duvadilan Tablet (50) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Duvadilan Tablet (50) as well, which are listed below. These side effects of Duvadilan Tablet (50) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Duvadilan Tablet (50)'s effect is Moderate during pregnancy and Mild for lactating mothers. Warnings related to Duvadilan Tablet (50)'s effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Bleeding, Heart Disease must refrain from the use of Duvadilan Tablet (50) since this can cause severe adverse effects.
Besides this, Duvadilan Tablet (50) may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Duvadilan Tablet (50) is not safe while driving, and is is not addictive in nature.
Duvadilan Tablet (50) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Adult |
|
Geriatric |
|
Is the use of Duvadilan Tablet (50) safe for pregnant women?
Pregnant women may experience moderate side effects from Duvadilan. It is best to stop taking Duvadilan immediately and inform your doctor if you notice any discomfort.
Is the use of Duvadilan Tablet (50) safe during breastfeeding?
Breastfeeding women can take Duvadilan as it bears very minor side effects for them.
What is the effect of Duvadilan Tablet (50) on the Kidneys?
Information about safety of Duvadilan for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of Duvadilan Tablet (50) on the Liver?
Side effects of Duvadilan on the liver are unknown because research on this has not been conducted yet.
What is the effect of Duvadilan Tablet (50) on the Heart?
Duvadilan has very mild side effects on the heart.
Duvadilan Tablet (50) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Duvadilan Tablet (50) unless your doctor advises you to do so -
Is this Duvadilan Tablet (50) habit forming or addictive?
No, there is no any evidence that Duvadilan Tablet (50) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Duvadilan Tablet (50), you should not drive or work on any heavy machine, as Duvadilan Tablet (50) can make you drowsy.
Is it safe?
Duvadilan Tablet (50) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Duvadilan Tablet (50) in mental disorders is not effective.
Interaction between Food and Duvadilan Tablet (50)
There isn't any research available on the side effects of taking Duvadilan Tablet (50) with food.
Interaction between Alcohol and Duvadilan Tablet (50)
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Duvadilan Tablet (50).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136